Mysoline
Mysoline

1.55
A generic medicine indicated for neurological conditions. Stabilises electrical activity within the brain to reduce the frequency and intensity of tremor symptoms.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Primidone
Reference Brand
Primidone
Product Origin
Generic Alternative
Reference Manufacturer
Valeant Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Barbiturate Anticonvulsant
Pharmacological Class
Antiepileptic Agent
Clinical Indications
Manufacturer Description
Utilized to manage cerebral seizure discharges to alleviate muscular convulsions and support motor baseline stability.
Mechanism of Action
Metabolizes into phenobarbital, maximizing GABA-mediated synaptic inhibition to raise the seizure threshold.
Route of Administration
Oral
Onset Time
2–4 days
Duration
24 hours
Contraindications
Porphyria, Hypersensitivity to phenobarbital
Severe Adverse Events
Suicidal ideation — requires immediate medical attention, Severe blood dyscrasias — requires immediate medical attention
Common Side Effects
Drowsiness, Dizziness, Nausea
Uncommon Side Effects
Ataxia, Nystagmus, Irritability
Drug Interactions
Warfarin, Oral Contraceptives, Phenytoin
Pregnancy Safety Warnings
TGA Category D: High risk of congenital malformations and neonatal hemorrhage. Breastfeeding: Avoid.
Age Restrictions
Approved for pediatric and adult populations.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Mysoline is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Asthma Treatment Australia - Seretide Accuhaler Price